NCT04906785View on ClinicalTrials.gov

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions

PHASE1UnknownINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

June 4, 2021

Primary Completion Date

July 30, 2021

Study Completion Date

August 6, 2021

Conditions
Cardiovascular Diseases
Interventions
DRUG

CKD-385

Test Drug

DRUG

D744

Reference Drug

Trial Locations (1)

Unknown

National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY